3 Buffett-Like Ways to Double Your Money in 2020

Hunting for a bargain? This group of beaten-down stocks, including Aurora Cannabis (TSX:ACB)(NYSE:ACB), might provide the value you’re looking for.

| More on:
Money growing in soil , Business success concept.

Image source: Getty Images

Hi there, Fools. I’m back to call attention to three stocks at new 52-week lows. Why? Because the big gains in the stock market are made by buying attractive companies

As legendary value investor Warren Buffett once quipped, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

So, if you’re looking to double your money in 2020, this is a good place to start your search.

Pot shots

Leading off our list is cannabis producer Aurora Cannabis (TSX:ACB)(NYSE:ACB), which is down a whopping 66% over the past year and currently trades at 52-week lows of $2.39 per share.

Rising costs, disappointing revenue growth, and concerns over a shaky balance sheet continue to weigh heavily on the stock. And most recently, Aurora’s chief corporate officer Cam Battley, one of the company’s most important executives, decided to step down.

On the positive side, Aurora remains a market share leader in the space, providing contrarian Fools with a possible long-term opportunity.

“Despite short term distribution and regulatory headwinds in Canada that have temporarily impacted the industry, the long-term opportunity for Aurora in the global cannabis and cannabinoids market is immense,” said CEO Terry Booth in November.

Aurora currently sports a beta of 1.6.

Important information

Next up, we have information management specialist Information Services (TSX:ISV), whose shares are off about 6% over the past six months and currently trade at 52-week lows of $15.19.

The stock has been pressured by lacklustre revenue growth over the past year, but now might be a prime opportunity to pounce. In the most recent quarter, for example, free cash flow remained strong at $6.6 million, as revenue improved to $32 million.

More importantly, the company remains on track to meet its full-year 2019 guidance.

“Our performance in the third quarter was as expected and we remain a strong free cash flow business,” said CEO Jeff Stusek. “Registry Operations continues to be challenged by the effects of economic conditions but is delivering robust results.”

Information Services currently offers a fat dividend yield of 5.2%.

Playing the organ

Rounding out our list is cannabis products specialist OrganiGram Holdings (TSX:OGI)(NASDAQ:OGI), which is down more than 50% over the past year and currently trades at 52-week lows of $2.64 per share.

Hurdles in the Canadian legal market for edibles, near-term uncertainty, and general industry concerns have weighed on the stock. But with that said, OrganiGram might now be too cheap to pass on.

In the most recent quarter, the company’s revenue popped 547%. More importantly, OrganiGram’s balance sheet remains relatively conservative.

“We have great conviction in our strategy and ability to onboard the new retail store openings and to launch a portfolio of edible and derivative products appealing to adult consumers,” said CEO Greg Engel. ”

OrganiGram shares trade at a forward P/E in he high teens.

The bottom line

There you have it, Fools: three ice-cold stocks worth checking out.

As always, don’t see them as formal recommendations. Instead, view them as a starting point for more research. Trying to catch a falling knife can be hazardous to your wealth, so plenty of homework is still required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool recommends OrganiGram Holdings and OrganiGram Holdings.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »